Thomas Krummel
Palo Alto, CANPI 1922140235
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $424,808 of the $488,508 with a category attached, or 87.0%. Procept Biorobotics Corporation accounts for 61.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $172,912 and has fallen 74.0% since, to $45,007 in 2024.
Across 121 payments — averaging $4037.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$301K
- Johnson & Johnson$147K
- Stryker$40K
- Edwards Lifesciences$213
What the payments were for
- Consulting fees$2,4250%
- Speaking & faculty fees$424,80887%
- Travel & lodging$16,5093%
- Food & beverage$4,6351%
- Gifts$400%
- Other$40,0918%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 114 | $300,841 |
| Johnson & Johnson | 4 | $147,363 |
| Stryker | 1 | $40,091 |
| Edwards Lifesciences | 2 | $213 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$253,644
- AQUABEAM SYSTEM$44,939
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.